This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB04276/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04276/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04276/identifier/pubchem-compound/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04276/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04276/identifier/drugbank/

Statements

Subject Item
n2:DB04276
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB04276 n8:DB04276
dcterms:title
N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine
adms:identifier
n10:30270 n11:DB04276 n12:46505123 n13:E64 n14:5288145
n4:IUPAC-Name
n5:271B4B0D-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B4B13-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B4B12-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B4B0F-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B4B10-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B4B11-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B4B0B-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B4B09-363D-11E5-9242-09173F13E4C5 n5:271B4B0C-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B4B0A-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B4B19-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B4B1A-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B4B14-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B4B15-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4B17-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4B16-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4B18-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B4B1F-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B4B21-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B4B22-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B4B1E-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B4B1D-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B4B20-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B4B0E-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B4B1B-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B4B1C-363D-11E5-9242-09173F13E4C5